Clinical Research in ALS (CRiALS)
CRiALS is an umbrella protocol through which people are recruited to participate in a range of research studies being conducted by the ALS Research Collaboration (ARC).
Amyotrophic Lateral Sclerosis
|Study Design:||Time Perspective: Prospective|
|Official Title:||Clinical Research in ALS|
- Recruitment [ Time Frame: Annually ]Since this is an umbrella/gateway protocol through which individuals are recruited to participate in a range of studies, outcome is assessed in terms of recruitment.
Biospecimen Retention: Samples With DNA
DNA, blood, urine, CSF, skin biopsies
|Study Start Date:||February 2005|
|Estimated Primary Completion Date:||September 2019 (Final data collection date for primary outcome measure)|
Research goals include elucidation of the complex relationship between ALS and related neurodegenerative disorders, development of both wet and dry biomarkers of disease, and delineation of the full course of the natural history of disease from the early pre-symptomatic stages through established and even late-stage disease. These goals are accomplished through the recruitment and evaluation of patients with ALS and related diseases, family members (including people at genetic risk for ALS, but who are not yet affected), and healthy controls.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00136500
|Contact: Eliana Reyesemail@example.com|
|United States, Florida|
|University of Miami||Recruiting|
|Miami, Florida, United States, 33136|
|Contact: Eliana Reyes 888-413-9315 firstname.lastname@example.org|
|Principal Investigator:||Michael Benatar, MD, PhD.||University of Miami|